Based on our experimental results, we hypothesized that IL-17A promoted NSCLC development by prompting the conversion of tumor cells to a pro-tumor growth phenotype and increasing PD-L1 expression. This evidence concerns the gene CD274 and non-small cell lung carcinoma.